Fertil Steril. 2006 Sep;86(3):742-4.

The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.

de Sa Rosa e Silva AC,Rosa e Silva JC,Nogueira AA, Petta CA,Abrao MS,Ferriani RA.

Department of Obstetrics and Gynecology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil. anasars@convex.com.br This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.

 

Women's Health



women's health

Please click on the required question.





Your Own Web Presence

 

For £35

 

 

FirstWebSiteDesign.com

 

Have your own web ad on the internet and optimized for good positioning.

 

Your Own Dedicated Web Page Designed Specifically For You

 

More Effective

Than Your Own

Single Page Website

 

For £35

 

 

FirstWebSiteDesign.com